摘要
Jenny Jing LIU 医师
皮肤科医师
Maximizing skin quality with resurfacing, lasers, and cosmeceuticals: A discussion on combining treatments to Chinese patients
Objectives: To demonstrate how combining conservative laser parameters with ingredient-specific cosmeceutical strategies can safely and effectively improve skin quality in Chinese patients.
Introduction: Chinese patients seeking skin rejuvenation often present with pigment concerns, textural irregularities, and sensitivity. However, Fitzpatrick III–IV skin types have a higher risk of PIH with energy-based treatments. This talk focuses on integrating safe procedural parameters and cosmeceuticals to optimize outcomes.
Materials / method: An integrative review of CO₂, Er:YAG, non-ablative fractional, and microneedling RF devices was performed with data from Chinese patient populations. Settings were evaluated in terms of safety, efficacy, and pigment response. Adjunct use of antioxidants, peptides, and barrier repair agents was mapped based on the 2024 JEADV consensus.
Results: Conservative settings (low density, low fluence, no stacking) reduced PIH risk post-fractional laser.
Microneedling RF and non-ablative fractional lasers showed high tolerability and effective outcomes in Chinese patients.
Post-procedure use of topical antioxidants and pigment modulators accelerated recovery and enhanced tone.
Zhang et al., JEADV 2024 consensus emphasized perioperative skincare as essential to procedural success in Chinese populations.
Conclusion: Maximizing skin quality in Chinese patients requires a balance between effective resurfacing and pigment-safe protocols. Conservative procedural parameters combined with post-treatment cosmeceutical support represent the optimal strategy for enhancing texture, tone, and clarity with minimal risk.
披露 - Jenny Jing LIU
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
Published on 2025年 10月 7日 - Recorded during IMCAS China 2025